Search Results for 'Olaparib-Parp'

Olaparib-Parp published presentations and documents on DocSlides.

by littleccas

actual. . video-recorded proceedings from the . l...

PARP Inhibitors This program will include a discussion of off-label treatment and investigational a

PARP Inhibitors This program will include a discussion of off-label treatment and investigational a

by conchita-marotz

PARP Inhibitors: What Do We know?. PARP Inhibitor...

PARP Inhibitors and Cancer: What Do You Need to Know?

PARP Inhibitors and Cancer: What Do You Need to Know?

by pasty-toler

This program will include a discussion of off-lab...

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

by alexa-scheidler

Phase I Study of Olaparib and Temozolomide, in pa...

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

by zen

knowledge. ). Incorporate evidence-based research ...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by blindnessinfluenced

proceedings from the live CME event and may includ...

Case Discussion: Second

Case Discussion: Second

by celsa-spraggs

Opinion. 55 year-old woman with . recurrent . ova...

by medshair

Five-year . survival. 15%. 30%. 40%. ?50%?. First ...

PARPA II: INDICADORES DE MONITORIA E AVALIAÇÃO

PARPA II: INDICADORES DE MONITORIA E AVALIAÇÃO

by calandra-battersby

PARPA II: INDICADORES DE MONITORIA E AVALIAÇÃO ...

PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update

PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update

by ellena-manuel

Program Overview . Discussion Outline. DNA Repair...

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,

by marina-yarberry

Niraparib. and . Temozolomide. in Patients with...

The Use of PARP Inhibitors in Breast Cancer: Challenges

The Use of PARP Inhibitors in Breast Cancer: Challenges

by calandra-battersby

and Opportunities. This program will include a di...

GU CONNECT PARP inhibitors in Prostate Cancer

GU CONNECT PARP inhibitors in Prostate Cancer

by jocelyn

Latest developments. . Prof.. . Neeraj Agarwal, ...

Updates in Ovarian Cancer Care

Updates in Ovarian Cancer Care

by ellena-manuel

Lisa McCluskey, MD. Gynecologic Oncologist. June ...

Patient Selection for PARP

Patient Selection for PARP

by sherrill-nordquist

Inhibitors:. Purpose and Practicalities . Present...

The Nurse View: Clinical Considerations in the Management of

The Nurse View: Clinical Considerations in the Management of

by natalia-silvester

BRCA. -Mutated Advanced Ovarian Cancer. Moderator...

Updates in Ovarian Cancer Care

Updates in Ovarian Cancer Care

by tatiana-dople

Lisa McCluskey, MD. Gynecologic Oncologist. June ...

8II251M8269GQ526E59I95Z95I58651I295I

8II251M8269GQ526E59I95Z95I58651I295I

by faith

:-;.*89! ! ! !"##$% & '&()%*#$+%#, & '&(-*."%/.#, ...

Triple Conjunction of Jupiter and Saturn

Triple Conjunction of Jupiter and Saturn

by marina-yarberry

(1352.3) 122:8.7 These wise men saw no star to gu...

Triple Conjunction of Jupiter and Saturn

Triple Conjunction of Jupiter and Saturn

by jane-oiler

(1352.3) 122:8.7 These wise men saw no star to gu...

What Clinicians Want to Know:

What Clinicians Want to Know:

by violet

Understanding the Factors Affecting the Optimal Di...

Year in Review Prostate Cancer

Year in Review Prostate Cancer

by faith

Emmanuel . S . Antonarakis. , MD. Professor of Onc...

Genomic Prostate Cancer Testing for Olaparib

Genomic Prostate Cancer Testing for Olaparib

by abigail

Laura Yarram-Smith . Solid Tumour Lead SWGLH. J...

NEw developments IN gynecological Oncology

NEw developments IN gynecological Oncology

by cheryl-pisano

highlights from the. EUROPEAN . society . of med...

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

by karlyn-bohler

Phase I Study of Olaparib and Temozolomide, in pa...

Ovarian cancer update Kentucky cancer Registry

Ovarian cancer update Kentucky cancer Registry

by danika-pritchard

9/8/2016 . Erica . Takimoto. , D.O., F.A.C.O.O.G....

1 Svetlana Jeremić 1 , Ana Kesić

1 Svetlana Jeremić 1 , Ana Kesić

by esther

2. , Jelena Đorović Jovanović. 2. , Biljana Pet...

Arsenic-Induces Dysfunction in Poly(ADP-Ribose) Polymerase-1:

Arsenic-Induces Dysfunction in Poly(ADP-Ribose) Polymerase-1:

by holly

Arsenic Contamination in Potable Water and an Asse...

Last edited 06112018

Last edited 06112018

by linda

DwACT ...

Policies Procedures and Documents

Policies Procedures and Documents

by naomi

Course Loads Full-Time and Half-Time DesignationPa...

PackageFOCIMarch192021TypePackageTitleFeatureOrderingbyConditionalI

PackageFOCIMarch192021TypePackageTitleFeatureOrderingbyConditionalI

by elysha

2codec codecEstimatetheconditionaldependencecoef&#...

A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy

A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy

by bikersjoker

patients with . advanced breast . cancer and a ger...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

by mitsue-stanley

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

Cancer Chemotherapy Part I: General Cancer Chemotherapy

Cancer Chemotherapy Part I: General Cancer Chemotherapy

by ellena-manuel

Chapter 16; Pages 797 to 815A. also Section 16.11...

Precision Medicine in the management of gynecologic cancers

Precision Medicine in the management of gynecologic cancers

by stefany-barnette

Randal West, MD. Ovarian cancer standard of care....

State of the Art in BRCA

State of the Art in BRCA

by ellena-manuel

-Mutated Ovarian Cancer. This program will includ...

Growth Patterns and Pathobiology of Experimental and

Growth Patterns and Pathobiology of Experimental and

by pamella-moone

Clinical Malignancies. In Vivo. Updated: March . ...

Service Provider Application

Service Provider Application

by sherrill-nordquist

NYC Recovers Fiscal Year 201 6 I. OVERVIEW ParP of...

by stefany-barnette

Knowledge Network. Accelerate . cancer R&D. B...

PCR Application:

PCR Application:

by alexa-scheidler

Can Breast Cancer be Cured?. Normal, Healthy Cell...